![Natalia Badillo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Natalia Badillo
Director of Finance/CFO at Friede & Goldman Ltd.
Natalia Badillo active positions
Companies | Position | Start | End |
---|---|---|---|
Friede & Goldman Ltd.
![]() Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Director of Finance/CFO | 2009-08-03 | - |
Career history of Natalia Badillo
Former positions of Natalia Badillo
Companies | Position | Start | End |
---|---|---|---|
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Director of Finance/CFO | - | - |
Training of Natalia Badillo
INSEAD | Masters Business Admin |
Statistics
International
United States | 2 |
Belgium | 2 |
France | 2 |
Operational
Director of Finance/CFO | 2 |
Masters Business Admin | 1 |
Sectoral
Industrial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Friede & Goldman Ltd.
![]() Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Industrial Services |
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
- Stock Market
- Insiders
- Natalia Badillo
- Experience